Pronounced weight gain frequently complicates insulin therapy in patients with type 2 diabetes (T2DM). We have previously reported that addition of liraglutide for 26 weeks can reverse insulin-associated weight gain, decrease insulin dose and improve glycaemic control, as compared with continuation of standard insulin treatment.To investigate whether the beneficial effects of liraglutide are sustained up to 52 weeks and whether similar effects could be obtained when liraglutide is added 6 months later.Adult T2DM patients with ≥ 4
作者:H M, de Wit;G M, Vervoort;H J, Jansen;B E, de Galan;C J, Tack
来源:Journal of internal medicine 2016 年 279卷 3期